Assessing tophaceous spinal gout treatment response using dual-energy CT as a point-of-care imaging modality: case report
- 23 December 2022
- journal article
- case report
- Published by Springer Nature in Skeletal Radiology
- Vol. 52 (8) , 1599-1604
Abstract
We describe a case of chronic tophaceous gout affecting the spine, hands, elbows, feet, and knees in a 67-year-old man with serum urate levels at 549 µmol/L whose response to treatment was successfully mapped using dual-energy computed tomography (DECT). The patient presented with exacerbation of acute-on-chronic lumbar back pain. He had received a diagnosis of gout 3 years prior to this presentation yet was not on any urate-lowering therapy. The patient received febuxostat 80 mg and colchicine 0.3 mg once daily and underwent DECT to assess baseline monosodium urate (MSU) burden. At baseline, MSU deposits were seen in the hands, elbows, feet, knees, and lumbar spine including the left L5–S1 facet joint encroaching onto the neural foramen. After 2.5 years of treatment, serum urate level was within the target range (< 360 µmol/L), and the patient underwent a follow-up DECT that revealed almost full resolution of MSU deposition in the spine, including the MSU-burdened facet joint and neural foramen in the lumbar spine, in addition to all the affected peripheral joints. This case is the first report of radiological evidence of nearly complete resolution of MSU deposits in spinal gout on DECT after urate-lowering therapy treatment, which demonstrates the utility of this imaging modality as a non-invasive investigational point-of-care imaging modality for mapping treatment response and identifying the etiology of back pain in a patient with chronic tophaceous spinal gout.Keywords
This publication has 25 references indexed in Scilit:
- Tophus resolution with pegloticase: a prospective dual-energy CT studyRMD Open, 2015
- Imaging in gout: A review of the recent developmentsTherapeutic Advances in Musculoskeletal Disease, 2014
- The application of dual-energy computed tomography in the diagnosis of acute gouty arthritisClinical Rheumatology, 2014
- Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal studyArthritis Research & Therapy, 2013
- Dual-Energy CT: A Promising New Technique for Assessment of the Musculoskeletal SystemAmerican Journal of Roentgenology, 2012
- Dual-Energy CT as a Potential New Diagnostic Tool in the Management of Gout in the Acute SettingAmerican Journal of Roentgenology, 2010
- Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient diseaseRheumatology International, 2009
- Dual energy computed tomography in tophaceous goutAnnals of the Rheumatic Diseases, 2009
- Noninvasive Differentiation of Uric Acid versus Non–Uric Acid Kidney Stones Using Dual-Energy CTAcademic Radiology, 2007
- Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with goutArthritis & Rheumatism, 2005